Test Price
2,800 AED✅ Home Collection Available
MTM1 Gene Myotubular Myopathy X‑Linked Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — Available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance to interpret your results with a specialist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced Next‑Generation Sequencing (NGS) genetic test provides definitive evidence for affected males, carrier identification in females, and family risk stratification — all processed within 3–4 weeks using ISO‑accredited protocols. The assay targets the MTM1 gene at Xq28, covering all coding exons, intronic boundaries, and deep intronic regions to detect single nucleotide variants, small insertions/deletions, and copy number changes.
| Feature | Our MTM1 NGS Test | Conventional Single‑Gene Analysis |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) — full gene coverage with deep intronic regions | Sanger sequencing or targeted MLPA — limited variant detection |
| Diagnostic Precision | >99.9% sensitivity for single nucleotide variants and copy number changes | May miss deep intronic or large rearrangement variants |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (often outsourced) |
| Sample Collection | Home‑based cold‑chain collection (8 AM–11 PM) | Clinic visit required |
| UAE Regulatory Compliance | Federal Decree‑Law No. 45 of 2021 (PDPL) & Federal Law No. 2 of 2019 (ICT in Health) | Variable adherence |
Physician Insight & Safety Protocols
“Comprehensive genomic analysis of the MTM1 gene offers definitive diagnostic clarity for X‑linked myotubular myopathy. However, genetic information must always be contextualised within the full clinical picture, three‑generation pedigree, and structured pre‑ and post‑test counselling. As a Consultant Medical Genetics specialist, I emphasise that this test is a guide for informed, evidence‑based care — not a standalone diagnosis. Family‑centred interpretation is essential for accurate recurrence risk assessment and reproductive planning.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Safety Advisory
Do not discontinue or modify any prescribed medication without explicit instruction from your treating physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent for genetic testing and pre‑test genetic counselling.
- Exclusion: Recent blood transfusion or bone marrow transplant within 4 weeks (may affect DNA extraction purity).
- Exclusion: Active severe infection or immunocompromised state requiring urgent medical management — postpone non‑urgent testing.
- Emergency: If the infant or child develops acute respiratory distress, severe hypotonia with feeding difficulties, or sudden loss of consciousness, go to the nearest emergency room immediately regardless of the test appointment.
Patient FAQ & Clinical Guidance
1. What does the MTM1 gene test diagnose?
Snippet: This test identifies pathogenic variants in the MTM1 gene to confirm X‑linked myotubular myopathy (XLMTM), a severe congenital neuromuscular disorder primarily affecting male infants.
The condition leads to profound muscle weakness, respiratory insufficiency, and often requires early intervention. Carrier detection in females supports family planning and recurrence risk assessment for future pregnancies. Genetic counselling before and after testing is mandatory to fully understand the implications.
2. How is the sample collected, and can I get home collection?
Snippet: We offer VIP Mobile Phlebotomy with ISO‑certified cold‑chain home collection from 8 AM to 11 PM, using a standard blood draw or a dried blood spot on an FTA card.
A trained phlebotomist visits your location with a temperature‑controlled kit. Minimal preparation is needed — just stay hydrated. The service is available across all Emirates; book via WhatsApp. For infants, a heel prick on FTA card is the gentlest option.
3. Will insurance cover the cost, and how soon will I get results?
Snippet: We provide direct billing verification via WhatsApp at +971 54 548 8731, and results are typically ready in 3–4 weeks after the sample arrives at the lab.
Our team will confirm your policy’s laboratory coverage before the draw. The turnaround time includes rigorous NGS analysis, bioinformatics interpretation, and a comprehensive clinical report. Urgent preliminary results can sometimes be expedited on a case‑by‑case basis.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. All laboratory processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | MTM1 Gene Myotubular Myopathy X‑Linked Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or Dried Blood Spot (FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | G71.2 |
| LOINC Code | 56949-5 |
| DHA Facility License & Laboratory Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians